1-3 of 3
Dingyao Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamic Single-Cell Profiling Reveals Novel Immune Regulatory Mechanism of ITK Inhibitor Soquelitinib in Refractory T Cell Lymphoma

Ning Ding, Yan Xie, Yong Guo, Kecheng Li, Tingting DU, Zhenjun Li, Yuejiao Li, Jiaowu Cao, Dingyao Hu, Lih-Yun Hsu, Richard Miller, Jun Zhu, Yuqin Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 1442.
https://doi.org/10.1182/blood-2023-174421
Published: 2023
Journal Articles

Combination of CDK4/6 Inhibitor Palbociclib and PI3K Inhibitor Idelalisib Synergistically Induces an Anti-Tumor Effect in B-Cell Lymphoma and Overcomes Ibrutinib Resistance

Dingyao Hu, Jiaowu Cao, Dedao Wang, Jiajin Wu, Lan Mi, Lingyan Ping, Ning Ding, Yuqin Song, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2826.
https://doi.org/10.1182/blood-2023-185912
Published: 2023
Journal Articles

Circulating Tumor DNA Clearance during Treatment As a Predictive and Prognostic Biomarker for Diffuse Large B-Cell Lymphoma Patients Receiving First-Line Therapy

Yuqin Song, Miaomiao Li, Lan Mi, Chunyang Wang, Xiaojuan Wang, Jianhua Zhu, Fei Qi, Hui Yu, Yingying Ye, Dedao Wang, Jiaowu Cao, Dingyao Hu, Quanyu Yang, Dandan Zhao, Tonghui Ma, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3527–3528.
https://doi.org/10.1182/blood-2022-166170
Published: 2022